United States Diabetic Neuropathy Market Report 2017

August 2017 | 109 pages | ID: U6A4BCC102BEN
QYResearch

Abstracts

In this report, the United States Diabetic Neuropathy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Diabetic Neuropathy in these regions, from 2012 to 2022 (forecast).

United States Diabetic Neuropathy market competition by top manufacturers/players, with Diabetic Neuropathy sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Johnson & Johnson
• Boehringer Ingelheim
• NeuroMetrix
• Astellas Pharma
• Eli Lilly
• GlaxoSmithKline
• Lupin Limited
• Depomed
• Glenmark Pharmaceuticals
• Arbor Pharmaceuticals

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Peripheral Neuropathy
• Autonomic Neuropathy
• Proximal Neuropathy
• Focal Neuropathy

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Diabetic Neuropathy for each application, including

• Hospitals
• Clinics
• Retail Pharmacy
• Online Pharmacy

Contents

United States Diabetic Neuropathy Market Report 2017

1 DIABETIC NEUROPATHY OVERVIEW

1.1 Product Overview and Scope of Diabetic Neuropathy
1.2 Classification of Diabetic Neuropathy by Product Category
  1.2.1 United States Diabetic Neuropathy Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Diabetic Neuropathy Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Peripheral Neuropathy
  1.2.4 Autonomic Neuropathy
  1.2.5 Proximal Neuropathy
  1.2.6 Focal Neuropathy
1.3 United States Diabetic Neuropathy Market by Application/End Users
  1.3.1 United States Diabetic Neuropathy Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Retail Pharmacy
  1.3.5 Online Pharmacy
1.4 United States Diabetic Neuropathy Market by Region
  1.4.1 United States Diabetic Neuropathy Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Diabetic Neuropathy Status and Prospect (2012-2022)
  1.4.3 Southwest Diabetic Neuropathy Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Diabetic Neuropathy Status and Prospect (2012-2022)
  1.4.5 New England Diabetic Neuropathy Status and Prospect (2012-2022)
  1.4.6 The South Diabetic Neuropathy Status and Prospect (2012-2022)
  1.4.7 The Midwest Diabetic Neuropathy Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Diabetic Neuropathy (2012-2022)
  1.5.1 United States Diabetic Neuropathy Sales and Growth Rate (2012-2022)
  1.5.2 United States Diabetic Neuropathy Revenue and Growth Rate (2012-2022)

2 UNITED STATES DIABETIC NEUROPATHY MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Diabetic Neuropathy Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Diabetic Neuropathy Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Diabetic Neuropathy Average Price by Players/Suppliers (2012-2017)
2.4 United States Diabetic Neuropathy Market Competitive Situation and Trends
  2.4.1 United States Diabetic Neuropathy Market Concentration Rate
  2.4.2 United States Diabetic Neuropathy Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Diabetic Neuropathy Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES DIABETIC NEUROPATHY SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Diabetic Neuropathy Sales and Market Share by Region (2012-2017)
3.2 United States Diabetic Neuropathy Revenue and Market Share by Region (2012-2017)
3.3 United States Diabetic Neuropathy Price by Region (2012-2017)

4 UNITED STATES DIABETIC NEUROPATHY SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Diabetic Neuropathy Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Diabetic Neuropathy Revenue and Market Share by Type (2012-2017)
4.3 United States Diabetic Neuropathy Price by Type (2012-2017)
4.4 United States Diabetic Neuropathy Sales Growth Rate by Type (2012-2017)

5 UNITED STATES DIABETIC NEUROPATHY SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Diabetic Neuropathy Sales and Market Share by Application (2012-2017)
5.2 United States Diabetic Neuropathy Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES DIABETIC NEUROPATHY PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Diabetic Neuropathy Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Diabetic Neuropathy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Johnson & Johnson
  6.2.2 Diabetic Neuropathy Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Johnson & Johnson Diabetic Neuropathy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Boehringer Ingelheim
  6.3.2 Diabetic Neuropathy Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Boehringer Ingelheim Diabetic Neuropathy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 NeuroMetrix
  6.4.2 Diabetic Neuropathy Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 NeuroMetrix Diabetic Neuropathy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Astellas Pharma
  6.5.2 Diabetic Neuropathy Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Astellas Pharma Diabetic Neuropathy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Eli Lilly
  6.6.2 Diabetic Neuropathy Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Eli Lilly Diabetic Neuropathy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 GlaxoSmithKline
  6.7.2 Diabetic Neuropathy Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 GlaxoSmithKline Diabetic Neuropathy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Lupin Limited
  6.8.2 Diabetic Neuropathy Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Lupin Limited Diabetic Neuropathy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Depomed
  6.9.2 Diabetic Neuropathy Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Depomed Diabetic Neuropathy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Glenmark Pharmaceuticals
  6.10.2 Diabetic Neuropathy Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Glenmark Pharmaceuticals Diabetic Neuropathy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Arbor Pharmaceuticals

7 DIABETIC NEUROPATHY MANUFACTURING COST ANALYSIS

7.1 Diabetic Neuropathy Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Diabetic Neuropathy

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Diabetic Neuropathy Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Diabetic Neuropathy Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES DIABETIC NEUROPATHY MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Diabetic Neuropathy Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Diabetic Neuropathy Sales Volume Forecast by Type (2017-2022)
11.3 United States Diabetic Neuropathy Sales Volume Forecast by Application (2017-2022)
11.4 United States Diabetic Neuropathy Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Diabetic Neuropathy
Figure United States Diabetic Neuropathy Market Size (K Units) by Type (2012-2022)
Figure United States Diabetic Neuropathy Sales Volume Market Share by Type (Product Category) in 2016
Figure Peripheral Neuropathy Product Picture
Figure Autonomic Neuropathy Product Picture
Figure Proximal Neuropathy Product Picture
Figure Focal Neuropathy Product Picture
Figure United States Diabetic Neuropathy Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Diabetic Neuropathy by Application in 2016
Figure Hospitals Examples
Figure Clinics Examples
Figure Retail Pharmacy Examples
Figure Online Pharmacy Examples
Figure United States Diabetic Neuropathy Market Size (Million USD) by Region (2012-2022)
Figure The West Diabetic Neuropathy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Diabetic Neuropathy Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Diabetic Neuropathy Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Diabetic Neuropathy Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Diabetic Neuropathy Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Diabetic Neuropathy Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Diabetic Neuropathy Sales (K Units) and Growth Rate (2012-2022)
Figure United States Diabetic Neuropathy Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Diabetic Neuropathy Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Diabetic Neuropathy Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Diabetic Neuropathy Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Diabetic Neuropathy Sales Share by Players/Suppliers
Figure 2017 United States Diabetic Neuropathy Sales Share by Players/Suppliers
Figure United States Diabetic Neuropathy Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Diabetic Neuropathy Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Diabetic Neuropathy Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Diabetic Neuropathy Revenue Share by Players/Suppliers
Figure 2017 United States Diabetic Neuropathy Revenue Share by Players/Suppliers
Table United States Market Diabetic Neuropathy Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Diabetic Neuropathy Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Diabetic Neuropathy Market Share of Top 3 Players/Suppliers
Figure United States Diabetic Neuropathy Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Diabetic Neuropathy Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Diabetic Neuropathy Product Category
Table United States Diabetic Neuropathy Sales (K Units) by Region (2012-2017)
Table United States Diabetic Neuropathy Sales Share by Region (2012-2017)
Figure United States Diabetic Neuropathy Sales Share by Region (2012-2017)
Figure United States Diabetic Neuropathy Sales Market Share by Region in 2016
Table United States Diabetic Neuropathy Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Diabetic Neuropathy Revenue Share by Region (2012-2017)
Figure United States Diabetic Neuropathy Revenue Market Share by Region (2012-2017)
Figure United States Diabetic Neuropathy Revenue Market Share by Region in 2016
Table United States Diabetic Neuropathy Price (USD/Unit) by Region (2012-2017)
Table United States Diabetic Neuropathy Sales (K Units) by Type (2012-2017)
Table United States Diabetic Neuropathy Sales Share by Type (2012-2017)
Figure United States Diabetic Neuropathy Sales Share by Type (2012-2017)
Figure United States Diabetic Neuropathy Sales Market Share by Type in 2016
Table United States Diabetic Neuropathy Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Diabetic Neuropathy Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Diabetic Neuropathy by Type (2012-2017)
Figure Revenue Market Share of Diabetic Neuropathy by Type in 2016
Table United States Diabetic Neuropathy Price (USD/Unit) by Types (2012-2017)
Figure United States Diabetic Neuropathy Sales Growth Rate by Type (2012-2017)
Table United States Diabetic Neuropathy Sales (K Units) by Application (2012-2017)
Table United States Diabetic Neuropathy Sales Market Share by Application (2012-2017)
Figure United States Diabetic Neuropathy Sales Market Share by Application (2012-2017)
Figure United States Diabetic Neuropathy Sales Market Share by Application in 2016
Table United States Diabetic Neuropathy Sales Growth Rate by Application (2012-2017)
Figure United States Diabetic Neuropathy Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Diabetic Neuropathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Diabetic Neuropathy Sales Growth Rate (2012-2017)
Figure Pfizer Diabetic Neuropathy Sales Market Share in United States (2012-2017)
Figure Pfizer Diabetic Neuropathy Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Diabetic Neuropathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Diabetic Neuropathy Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Diabetic Neuropathy Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Diabetic Neuropathy Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Diabetic Neuropathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Diabetic Neuropathy Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Diabetic Neuropathy Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Diabetic Neuropathy Revenue Market Share in United States (2012-2017)
Table NeuroMetrix Basic Information List
Table NeuroMetrix Diabetic Neuropathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure NeuroMetrix Diabetic Neuropathy Sales Growth Rate (2012-2017)
Figure NeuroMetrix Diabetic Neuropathy Sales Market Share in United States (2012-2017)
Figure NeuroMetrix Diabetic Neuropathy Revenue Market Share in United States (2012-2017)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Diabetic Neuropathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Astellas Pharma Diabetic Neuropathy Sales Growth Rate (2012-2017)
Figure Astellas Pharma Diabetic Neuropathy Sales Market Share in United States (2012-2017)
Figure Astellas Pharma Diabetic Neuropathy Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Diabetic Neuropathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Diabetic Neuropathy Sales Growth Rate (2012-2017)
Figure Eli Lilly Diabetic Neuropathy Sales Market Share in United States (2012-2017)
Figure Eli Lilly Diabetic Neuropathy Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Diabetic Neuropathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Diabetic Neuropathy Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Diabetic Neuropathy Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Diabetic Neuropathy Revenue Market Share in United States (2012-2017)
Table Lupin Limited Basic Information List
Table Lupin Limited Diabetic Neuropathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lupin Limited Diabetic Neuropathy Sales Growth Rate (2012-2017)
Figure Lupin Limited Diabetic Neuropathy Sales Market Share in United States (2012-2017)
Figure Lupin Limited Diabetic Neuropathy Revenue Market Share in United States (2012-2017)
Table Depomed Basic Information List
Table Depomed Diabetic Neuropathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Depomed Diabetic Neuropathy Sales Growth Rate (2012-2017)
Figure Depomed Diabetic Neuropathy Sales Market Share in United States (2012-2017)
Figure Depomed Diabetic Neuropathy Revenue Market Share in United States (2012-2017)
Table Glenmark Pharmaceuticals Basic Information List
Table Glenmark Pharmaceuticals Diabetic Neuropathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Glenmark Pharmaceuticals Diabetic Neuropathy Sales Growth Rate (2012-2017)
Figure Glenmark Pharmaceuticals Diabetic Neuropathy Sales Market Share in United States (2012-2017)
Figure Glenmark Pharmaceuticals Diabetic Neuropathy Revenue Market Share in United States (2012-2017)
Table Arbor Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Diabetic Neuropathy
Figure Manufacturing Process Analysis of Diabetic Neuropathy
Figure Diabetic Neuropathy Industrial Chain Analysis
Table Raw Materials Sources of Diabetic Neuropathy Major Players/Suppliers in 2016
Table Major Buyers of Diabetic Neuropathy
Table Distributors/Traders List
Figure United States Diabetic Neuropathy Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Diabetic Neuropathy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Diabetic Neuropathy Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Diabetic Neuropathy Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Diabetic Neuropathy Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Diabetic Neuropathy Sales Volume (K Units) Forecast by Type in 2022
Table United States Diabetic Neuropathy Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Diabetic Neuropathy Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Diabetic Neuropathy Sales Volume (K Units) Forecast by Application in 2022
Table United States Diabetic Neuropathy Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Diabetic Neuropathy Sales Volume Share Forecast by Region (2017-2022)
Figure United States Diabetic Neuropathy Sales Volume Share Forecast by Region (2017-2022)
Figure United States Diabetic Neuropathy Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources